inclusion criteria: 1. participants who have a positive sars-cov-2 test result ; 2. participants who have been diagnosed with mild or ordinary type of covid-19 infection; 3. participants whose serum hyaluronic acid level was higher than the upper limit of normal value; 4. participants who must agree to adhere to contraception restrictions; 5. participants who understand and agree to comply with planned study procedures; 6. participants who give signed consent which includes compliance with the requirements and restrictions listed in the informed consent form (icf) and in this protocol.

inclusion criteria: 1. participants who have a positive sars-cov-2 test result ; 2. participants who have been diagnosed with mild or ordinary type of covid-19 infection; 3. participants whose serum hyaluronic acid level was higher than the upper limit of normal value; 4. participants who must agree to adhere to contraception restrictions; 5. participants who understand and agree to comply with planned study procedures; 6. participants who give signed consent which includes compliance with the requirements and restrictions listed in the informed consent form (icf) and in this protocol.

inclusion criteria: participants who have a positive sars-cov-2 test result ; participants who have been diagnosed with mild or ordinary type of covid-19 infection; participants whose serum hyaluronic acid level was higher than the upper limit of normal value; participants who must agree to adhere to contraception restrictions; participants who understand and agree to comply with planned study procedures; participants who give signed consent which includes compliance with the requirements and restrictions listed in the informed consent form (icf) and in this protocol.

inclusion criteria: participants who have a positive sars-cov-2 test result ; participants who have been diagnosed with mild or ordinary type of covid-19 infection; participants whose serum hyaluronic acid level was higher than the upper limit of normal value; participants who must agree to adhere to contraception restrictions; participants who understand and agree to comply with planned study procedures; participants who give signed consent which includes compliance with the requirements and restrictions listed in the informed consent form (icf) and in this protocol.

inclusion criteria: participants who have a positive sars-cov-2 test result and the ct value is ≤30 according to the result of fluorescence quantitative pcr; participants who have been diagnosed with mild or ordinary type of covid-19 infection; participants whose serum hyaluronic acid level was higher than the upper limit of normal value; participants who must agree to adhere to contraception restrictions; participants who understand and agree to comply with planned study procedures; participants who give signed consent which includes compliance with the requirements and restrictions listed in the informed consent form (icf) and in this protocol.

inclusion criteria: participants who have a positive sars-cov-2 test result and the ct value is ≤30 according to the result of fluorescence quantitative pcr; participants who have been diagnosed with mild or ordinary type of covid-19 infection; participants whose serum hyaluronic acid level was higher than the upper limit of normal value; participants who must agree to adhere to contraception restrictions; participants who understand and agree to comply with planned study procedures; participants who give signed consent which includes compliance with the requirements and restrictions listed in the informed consent form (icf) and in this protocol.